OraSure Technologies | OSUR - Cash And Equivalent


OraSure Technologies reported $160.58M in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
Agilent USD 1.81B 49M Mar/2026
AngioDynamics USD 41.64M 14.26M Sep/2025
Becton, Dickinson and Co. USD 708M 105M Jun/2026
Bio Techne USD 264.71M 54.89M Jun/2026
Bio-Rad Laboratories USD 517M 9.8M Jun/2026
Bruker USD 184.9M 51.5M Jun/2026
Cerus USD 19.96M 4.29M Dec/2025
Charles River Laboratories USD 192.02M 195K Jun/2026
Danaher USD 4.35B 1.35B Jun/2026
Dentsply International USD 239M 49M Jun/2026
Dexcom USD 1.1B 13.2M Jun/2026
Illumina USD 1.09B 329M Mar/2026
Integra LifeSciences USD 214.42M 22.39M Jun/2026
Intuitive Surgical USD 8.63B 646.3M Jun/2026
IQVIA Holdings USD 1.91B 38M Jun/2026
Mesa Laboratories USD 28.98M 8.55M Dec/2025
Mettler Toledo International USD 51.38M 9.19M Jun/2026
Myriad Genetics USD 115.2M 9.2M Jun/2026
OraSure Technologies USD 160.58M 16.38M Jun/2026
Quidel USD 123.4M 17M Jun/2026
Repligen USD 606.78M 24.13M Jun/2026
Revvity USD 1.02B 162.62M Jun/2026
STAAR Surgical USD 148.58M 16.72M Jun/2026
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Trinity Biotech USD 5.14M 3.8M Dec/2025
Waters USD 539M 77M Jun/2026